Pain Management in Osteoporosis.
Rajesh Kumar RajnishAbhay ElhenceS S JhaPalanisami DhanasekararajaPublished in: Indian journal of orthopaedics (2023)
The most prevalent metabolic bone disease, osteoporosis, is characterized by a decrease in bone mineral density and alterations to the bone's microstructure, both of which can result in fragility fractures. It affects a significant section of the population. Acute or chronic pain from these fractures is typical in elderly adults with other coexisting conditions. Since the antiresorptive medication only partially reduces pain, other analgesics are required for effective pain management. NSAIDs or selective COX-2 inhibitors can reduce acute pain, but persistent neuropathic pain is difficult to manage with these drugs. Opioids have their adverse effects and safety concerns, although they can be used to address acute or chronic pain. Hence, a multifaceted approach is to be implemented, including pharmacological and nonpharmacological therapy and surgical treatment in a selected number of cases. This chapter briefly describes the etiology of pain, its mechanism, and pain management in osteoporotic patients.
Keyphrases
- pain management
- bone mineral density
- chronic pain
- postmenopausal women
- neuropathic pain
- liver failure
- body composition
- respiratory failure
- drug induced
- spinal cord
- end stage renal disease
- aortic dissection
- spinal cord injury
- ejection fraction
- chronic kidney disease
- hepatitis b virus
- extracorporeal membrane oxygenation
- prognostic factors
- mesenchymal stem cells
- electronic health record
- acute respiratory distress syndrome
- middle aged
- bone loss
- replacement therapy